MedPath

Treatment of Chronic RhinoSinusitis (Inflamation of Sinusis and Nasal cavity) with Unani medicine Itrifal Kishneezi

Phase 3
Conditions
Health Condition 1: J329- Chronic sinusitis, unspecified
Registration Number
CTRI/2019/03/017945
Lead Sponsor
Central Council for Research in Unani Medicine CCRUM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of either sex of age 18-65 years

2. Patients with Sino-Nasal Outcome Test (SNOT) > 7

3. Patients clinically diagnosed of sinusitis of duration > 12 weeks with radiological changes.

Exclusion Criteria

1. Patients of sinusitis with epistaxis, hypertension shall be excluded from the study

2. Patient having any growth in the nose like nasal polyps etc.

3. Patients with co-morbidity requiring long term treatment.

4. Pregnant and lactating females.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in sign and symptoms of Nazla Muzmin (Chronic RhinoSinusitis)Timepoint: 04 Weeks
Secondary Outcome Measures
NameTimeMethod
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment
© Copyright 2025. All Rights Reserved by MedPath